Sonoma Pharmaceuticals, INC. (SNOA) — DEF 14A Filings
All DEF 14A filings from Sonoma Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Sonoma Pharma Details Executive Pay, Governance Ahead of Shareholder Vote
— Jul 11, 2025 Risk: medium
Sonoma Pharmaceuticals, Inc. (SNOA) filed its DEF 14A, indicating a focus on executive compensation and corporate governance for the fiscal year ending March 31 -
Sonoma Pharmaceuticals Files Definitive Proxy Statement
— Jul 1, 2024 Risk: low
Sonoma Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEF 14A) on July 1, 2024, for the fiscal year ending March 31, 2024. The company, formerly know
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX